Overview
Intravenous Tranexamic Acid Versus IV Carbetocin in Abdominal Myomectomy
Status:
Not yet recruiting
Not yet recruiting
Trial end date:
2020-10-20
2020-10-20
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
the aim of the present study is to compare safety and efficacy of intravenous tranexamic acid versus IV carbetocin in reducing blood loss during abdominal myomectomy: a randomized controlled trialPhase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Cairo UniversityTreatments:
Carbetocin
Tranexamic Acid
Criteria
Inclusion Criteria:- women with symptomatic fibroids candidate for abdominal myomectomy with staging of
myoma from (3 to 6) according to FIGO staging
Exclusion Criteria:
- women with Myoma FIGO staging (1,2,7 and 8) candidate for laparoscopic or
hysteroscopic myomectomy, women with allergy or contraindications to carbetocin or
tranexamic acid